Crossmark

Daptomycin versus beta-lactam based therapy for the treatment of enterococcal endocarditis and other endovascular infections: a retrospective cohort study

Crossref DOI link: https://doi.org/10.1186/s12879-025-11697-6

Published Online: 2025-10-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Perera, Vindya

Wardlow, Lynn

Sobhanie, Mohammad M.

Coe, Kelci

Leininger, Jessica M.
Funding

Funding for this research was provided by:

National Center for Advancing Translational Sciences (UL1TR002733)
License Information

Text and Data Mining valid from 2025-10-21

Version of Record valid from 2025-10-21
More Information

Article History

Received: 27 June 2025

Accepted: 15 September 2025

First Online: 21 October 2025

Declarations

:

: This study was conducted following the Declaration of Helsinki and approved by the Ohio State Biomedical Sciences Institutional Review Board (study 2023H0348) with a waiver of informed consent granted.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below